• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HU Jie,HUANG Fang.Research progress on drug action pathways and targets for treating polycystic ovary syndrome[J].Journal Of Pharmaceutical Research,2020,39(10):585-589[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2757times   Download 2869次 QR Code for this article
Scan with your phone!
治疗多囊卵巢综合征药物作用通路及靶点的研究进展
胡婕,黄芳
Font:Larger+|Default|Smaller-
(中国药科大学中药学院中药药理与中医药学系,江苏 南京 211198)
摘要:
多囊卵巢综合征(PCOS)是育龄妇女最常见的内分泌疾病。 其发病机制复杂,包含生殖,内分泌,代谢和心理等各方面因素,因此多囊卵巢综合征的病因仍然未知。多囊卵巢综合征女性出现心血管疾病、骨质疏松症和癌症的风险较高,严重威胁女性的健康和生存质量。本文对改善和治疗多囊卵巢综合征常见的药物作用通路及靶点进行介绍,以便发现更好的治疗药物,改善多囊卵巢综合征患者的生活质量。
关键词:  多囊卵巢综合征  药物作用信号通路  靶点  胰岛素抵抗  研究进展
DOI:10.13506/j.cnki.jpr.2020.10.008
基金项目:江苏省科技计划项目(No.SBK2019021355)
Research progress on drug action pathways and targets for treating polycystic ovary syndrome
HU Jie,HUANG Fang
(Department of Pharmacology of Chinese Materia Medica,Chinese Pharmacology and Department of Traditional Chinese Medicine,China Pharmaceutical University,Nanjing 211198,China)
Abstract:
Polycystic ovary syndrome( PCOS) is a common reproductive endocrine disorders in gynecology.Its pathogenesis is complex, including factors such as reproduction, endocrine, metabolism and psychology.The pathogenesis of polycystic ovary syndrome is still unknown. Women with polycystic ovary syndrome are at higher risk for cardiovascular disease, osteoporosis, and cancer, which has a significant impact on women's health and quality of life. This article introduced the pathways and targets for improving and treating polycystic ovary syndrome, in order to find better drugs to improve the patient's quality of life.
Key words:  Polycystic ovary syndrome  Signaling pathways of drug action  Targets  Insulin resistance  Advances in research
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.